ReportsnReports.com adds new research study on “Mesenchymal Stem Cells – Advances & Applications” to its database.
Put simply, this report will help you understand and profit from the mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research.
Updated to reflect the most current trends and including five year market projections, this report focuses on the advances in MSC research. In 125 pages you’ll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.
If you’re looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. And buy today to get our 60-day money-back guarantee.
Claiming Fast-Growth Opportunities for Yourself
Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=10598.
Revealing Unique Strategic Opportunities & Unknown Competitive Advantages
MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.
This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.
Expanded and Updated Market Intelligence
This is an expanded and updated market intelligence report that includes:
Updated Charts, Timelines, Metrics and Financials
5-Year Projection Data through 2016
Expanded Competitive Environment Analysis
Detailed Characterization of the Market, Emphasizing Statistical Trends
Exploration of Recent Product Evolution and Projected Directions for Development
Overview of Therapeutic Progress and Insight into Future Applications
Detailed Evaluation of Profit Opportunities
New Section on End-User Needs & Technical Preferences (Scientist Survey!)
Get more details @ http://www.reportsnreports.com/reports/10598-mesenchymal-stem-cells-advances-applications.html.
Contact [email protected] for further information.